Cover photo
Uday Shetty
Works at Drug Regulations
Attended University department of Chemical Technology
Lives in Mumbai


Uday Shetty

Shared publicly  - 
FDA Issues Final Guidance on " Naming of Drug Products containing Salt Drug Substances.
FDA has issued final guidance detailing naming and labeling
for drug products that contain an active ingredient that is a salt.  The guidance is intended to outline how
products with active ingredients that are salts may be affected by CDER's
Add a comment...

Uday Shetty

Shared publicly  - 
FDA Issues draft guidance on Quality Metrics.
FDA has released draft
guidance for the pharmaceutical industry called,  “Request
for Quality Metrics.” This document describes a set
of measurements to help the FDA evaluate the quality of the facilities and the
processes that manufacturers use to make FDA...
Add a comment...

Uday Shetty

Shared publicly  - 
Presentation on " Continued Process Validation"
FDA Process Validation Guidance (Guidance for Industry:
Process Validation- General Principles and Practices, Jan. 2011) outlines
process validation activities in three stages - Stage 1: Process Design, Stage
2: Process Qualification and Stage 3: Continued ...
Add a comment...

Uday Shetty

Shared publicly  - 
US FDA Issues Final Guidance on Analytical Procedures & Method Validaion
FDA is announcing the
availability of guidance for industry entitled “Analytical Procedures and
Methods Validation for Drugs and Biologics.” This guidance supersedes
the draft of the same name that published on February 19, 2014, and replaces
the 2000 draft...
Add a comment...

Uday Shetty

Shared publicly  - 
Add a comment...
Quality Management
  • Drug Regulations
    Founder, 2010 - present
  • Pharmabiz
    Director, 2012 - present
  • Janssen Pharmaceutica
    Site Head & VP, 1990 - 2010
Map of the places this user has livedMap of the places this user has livedMap of the places this user has lived
Mumbai - Mumbai
Contact Information
Dr. Shetty is a  Pharmaceutical Management Professional with extensive experience in quality management, product development, technology transfers, commercial product support. His specialized expertise includes  contract manufacturing and process validations.  He has Supervisory experience in support functions like EHS, engineering and purchase.He is Quick and innovative thinker with ability to adapt rapidly to dynamic situations and is a consummate team player. 

In the immediate past he was the  Director at Contract Research Organization which he co-founded. Before that he was in leading Pharmaceutical companies like Janssen,GSK and Wyeth.He supervised large teams of Quality assurance, Quality Control and Product development. As a site head with Janssen he also supervised  general management functions like Finance, Purchase, Imports, engineering, EHS and Project Management. Dr. Shetty has set up, nurtured and grew number of organizations to deliver superior business results in the field of Quality management , Contract Research and Manufacturing. His specialties include Quality Management and Product Development. 
  • University department of Chemical Technology
    Pharmaceutical Technology, 1976 - 1984
Basic Information
Uday Shetty's +1's are the things they like, agree with, or want to recommend.
“No company will live or die because of high price premiums for drugs bu...

Reuters recently reported that Swiss drugmaker Roche plans to offer two blockbuster cancer drugs to the Indian consumers at significantly re

FDA issues a new SOP dealing with cargo thefts.

Warehouse thefts like Lilly's in 2010 are on the rise. Cargo theft mainly occurs during transportation as thieves make off with unattend

New PIC/S Recommendation for Risk-Based Inspection Planning in the GMP E...

This PIC/S Recommendation sets out a simple and flexible Quality Risk Management tool that may be used by Inspectorates when planning the fr

EMA's International Collaboration on Good Manufacturing Practice Inspect...

The European Medicines Agency has expanded the scope of the International Collaboration on Good Manufacturing Practice Inspection. The overa

FDA issues final rule for control & use of cut lables.

Due to significant problems with label mix ups and consequent recalls, FDA in 1987 and in 1990 reviewed the labeling procedures. The review

New FDA Draft Guidance on Appropriate Size Range for Beads Administered ...

Certain drug products that contain beads within a capsule indicate in the labeling that the capsule can be broken and the internal beads can

Should India Modify the Compulsory Licensing Provision of the Patent Law?

On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license

New FDA and EU regulations for packing of medicines.

Falsified medicines or counterfeits are a big problem in many parts of the world and has significant implications for patient safety. It als

New EU recommendations for laboratories that perform analysis of clinica...

Analysis and evaluation of samples collected from subjects participating in clinical trials forms a key part of the clinical trials process.

Is continuing manufacturing when acceptable smoke test results are await...

A scrutiny of the 483's and warning letters issued by the FDA in the last year or so indicate increasing vigilance of FDA on aseptic pro

Does WEST have monopoly over Moral and Ethical standards?

Chris Hansen of "Dateline" journeyed to India to expose CROs for indulging in unethical practices... Using publicly available info

New FDA guidance on Stability Evaluation

FDA has issued new draft guidance for Veterinary Medicine (CVM) which aims to implement the ICH requirements for Registration of Veterinary

Should Novartis withdraw the Patent Law challenge in India for Increment...

Ahead of the hearing of patent litigation for its anti-cancer drug Glivec in Supreme Court later this month, Novartis has said the outcome o

New FDA draft guidance on the use of Phthalates as Excipients.

Phthalate esters are synthetic chemicals with a broad spectrum of uses. Phthalates are found in certain pharmaceutical formulations, primari

Authorized Generics

Competition from authorized generics during the 180-day marketing exclusivity period has led to lower retail and wholesale drug prices. Spec

ICH S10 Guideline reaches Step 2 of the ICH Process

The purpose of this document is to recommend international standards for photosafety assessment, and to harmonise such assessments supportin

From Tylenol to Tylenol - A Missed Opportunity

Once upon a time many Johnsonian's and Ex-Johnsonian's were admirers of the J and J credo in light of the extraordinary positive les

Are Quality Professionals caught between the Devil and the Deep Sea ?

During last year Quality professionals have seen two large companies; Ranbaxy and Johnson and Johnson enter into a consent decree with the U